Squeezy Connect

About Squeezy Connect Android App

Squeezy Connect supports pelvic health treatment programmes when working with a specialist pelvic health clinician.

To access, you need an invitation from your clinician asking you to register onto the Living With platform.

Not sure if you can access? Ask your clinician if they have this service. Or register your interest: livingwith.health/request-squeezyconnect

About Squeezy Connect:

Squeezy Connect (previously called SqueezyCX) is the connected version of the pelvic floor muscle exercise app Squeezy.

It allows you to share exercise plans and records, securely with your clinician. This enables clinicians to monitor your activity and progress, as part of your treatment programme.

Designed by chartered physiotherapists specialising in pelvic health working in the NHS, it is simple to use and informative.

Features include:
• Exercise plans for slow/quick/submax exercises that can be tailored according to your treatment programme
• Exercise reminders with customisable settings
• Visual and audio prompts for exercises
• A record of the number of exercises you have completed, compared to your target
• Educational information about the pelvic floor
• Bladder diary to keep track of your symptoms, if required
• ICIQ-UI to keep track of your progress
• Simple and clear interface

Getting support:
You can visit the support pages for articles on how to resolve any problems you may come across: support.livingwith.health
For further help you can submit a support ticket to the helpdesk: follow the link to “Submit a request”.

Squeezy Connect has been clinically reviewed and approved by the NHS for its clinical safety, and is compliant with NHS Information Governance requirements.

The original Squeezy won several industry awards including ehi Awards 2016, Health Innovation Network 2016, National Continence Care Awards 2015/16 and was finalist for awards including Advancing Healthcare Awards 2014 and 2017, Abbvie Sustainable Healthcare Awards 2016.

The app is UKCA marked as Class I medical device in the United Kingdom and developed in compliance with Medical Devices Regulations 2002 (SI 2002 No 618, as amended).